Skip to main content

Table 3 Meta-analysis of effects of microwave ablation versus radiofrequency ablation on HCCs

From: Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis

 

CTA

1-year SR

3-year SR

OS

LTR

Major complications

Cohort

studies

MWA 86.7–100%

MWA 81.6–98%

MWA 49–79%

HR 0.80

OR 0.95

OR 1.23

RFA 83.9–100%

RFA 67.6–98.7%

RFA 37.6–82.7%

95% CI 0.62–1.04

95% CI 0.64–1.41

95% CI 0.45–3.37

P > 0.05

P > 0.05

P > 0.05

   

[9,10,11,12,13,14]

[9,10,11,12,13,14]

[9,10,11,12,13,14]

[9,10,11,12,13,14]

[9,10,11,12,13,14]

[10,11,12]

RCT

MWA 89.1–96.1%

NA

NA

HR 0.58

OR 1.19

OR 0.80

RFA 89.5–95.8%

  

95% CI 0.22–1.56

95% CI 0.20–7.06

95% CI 0.26–2.49

P > 0.05

     

[15,16,17]

  

[15, 17]

[15,16,17]

[15, 16]

  1. CTA complete tumor ablation, SR survival rates, OS overall survival, LTR local tumor recurrence, MWA microwave ablation, RFA radiofrequency ablation, HR hazard ratio, RCT randomized controlled trial, NA not applicable. Those in square brackets were numbers of references